BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $424,000 | -14.0% | 3,575 | 0.0% | 0.19% | +2.2% |
| Q4 2021 | $493,000 | -22.1% | 3,575 | -21.6% | 0.19% | -33.3% |
| Q3 2021 | $633,000 | +31.1% | 4,558 | -8.3% | 0.28% | +40.2% |
| Q2 2021 | $483,000 | -1.8% | 4,973 | -30.9% | 0.20% | -4.3% |
| Q1 2021 | $492,000 | -18.0% | 7,193 | +2.8% | 0.21% | -16.5% |
| Q4 2020 | $600,000 | +97.4% | 6,997 | +49.8% | 0.25% | +56.6% |
| Q3 2020 | $304,000 | -21.9% | 4,671 | -12.2% | 0.16% | -13.6% |
| Q2 2020 | $389,000 | +67.0% | 5,318 | -22.4% | 0.18% | +91.7% |
| Q1 2020 | $233,000 | -45.6% | 6,857 | -12.8% | 0.10% | +37.1% |
| Q4 2019 | $428,000 | +154.8% | 7,860 | +95.2% | 0.07% | +105.9% |
| Q3 2019 | $168,000 | -9.7% | 4,026 | -5.2% | 0.03% | -12.8% |
| Q2 2019 | $186,000 | -51.2% | 4,249 | -42.7% | 0.04% | -95.2% |
| Q1 2019 | $381,000 | +23.7% | 7,409 | -10.9% | 0.81% | +1430.2% |
| Q4 2018 | $308,000 | -29.5% | 8,320 | -28.4% | 0.05% | +17.8% |
| Q3 2018 | $437,000 | -45.1% | 11,625 | -42.3% | 0.04% | -93.6% |
| Q2 2018 | $796,000 | – | 20,154 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |